{"id":50945,"name":"MCDERMOTT WILL & EMERY LLP (OBO ALNYLAM PHARMACEUTICALS)","slug":"mcdermott-will-emery-llp-obo-alnylam-pharmaceuticals","state":"CA","country":"United States of America","description":"Biopharmaceuticals.","totalSpending":300000,"filings":6,"yearlySpending":[{"year":2022,"income":260000},{"year":2023,"income":40000}],"issues":[{"code":"CPT","display":"Copyright/Patent/Trademark"},{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"}],"firms":["TIBER CREEK GROUP"],"lobbyists":["TIMOTHY MOLINO","JOHN GONZALEZ","COREY MALMGREN","JONATHON JONES","BRYANT HALL","TIMOTHY ROBINSON"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Issues related to COVID-19 vaccines.","Issues related to COVID-19 vaccines.","Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169).","Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169)."]}